NCPA, NACDS file injunction to stop AMP
NCPA and NACDS have filed a preliminary injunction against CMS to stop the implementation of its average manufacturer price rule.
NCPA and NACDS have asked a federal court to issue a preliminary injunction to stop CMS from following through on its plans to implement the average manufacturer price rule. Last week, the organizations report authored by Stephen W. Schondelmeyer, Pharm.D., Ph.D., of the College of Pharmacy at the University of Minnesota. The report found that the AMP rule could result in the loss of more than 10,000 pharmacies.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
